4//SEC Filing
THON RICHARD 4
Accession 0001179110-09-013945
CIK 0001222244other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 5:44 PM ET
Size
12.5 KB
Accession
0001179110-09-013945
Insider Transaction Report
Form 4
THON RICHARD
Chief Financial Officer
Transactions
- Award
Stock options
2009-09-29+60,000→ 60,000 totalExercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (60,000 underlying)
Holdings
- 1,000(indirect: Options held by son, Eric Thon)
Stock options
Exercise: $11.33Exp: 2012-04-18→ Common stock, $0.00001 par value (1,000 underlying) - 45,000
Stock Options
Exercise: $0.85Exp: 2016-03-03→ Common stock, $0.00001 par value (45,000 underlying) - 35,000
Stock options
Exercise: $1.00Exp: 2015-07-11→ Common stock, $0.00001 par value (35,000 underlying) - 5,000
Stock options
Exercise: $7.50Exp: 2011-03-02→ Common stock, $0.00001 par value (5,000 underlying) - 2,000
Stock options
Exercise: $11.33Exp: 2012-04-18→ Common stock, $0.00001 par value (2,000 underlying)
Footnotes (4)
- [F1]Immediately exercisable.
- [F2]Exercisable as to 18,333share immediately; remaining options vest as to 8,333 shares on July 1, 2010, and 8,334 shares on July 1, 2011.
- [F3]Options shall vest on the date the Company is cleared by the FDA to sell the ProUroScan Sytem in the United States.
- [F4]Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant(including the exercise of existing warrants).).
Documents
Issuer
ProUroCare Medical Inc.
CIK 0001222244
Entity typeother
Related Parties
1- filerCIK 0001285622
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 5:44 PM ET
- Size
- 12.5 KB